Feed 600613.SS
60

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. 600613.SS SHH · Healthcare · China

¥5.27 -5.22% -¥0.29

Market cap
¥2.97B
Enterprise value
¥2.48B
P/E
343.1x
Forward P/E
-
PEG
-
P/S
1.6x
P/FCF
32.1x
EV/EBITDA
23.9x
ROIC
1.1%
Gross margin
43.1%
Net margin
0.5%
Dividend yield
1.26%
Payout ratio
432.0%
Net debt/EBITDA
-4.7x
Beta
0.41
Free float
44.2%

Sector

Healthcare

Industry

Drug Manufacturers - General

CEO

Feng Bin

Employees

1,196

Headquarters

Shanghai

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

  • What to watch: Revenue fell by 6.5% a year over the last 3 years.

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

  • What speaks for it: It has been profitable 5 years in a row.
  • What to watch: Out of every 100 CNY of revenue, only 0.5 CNY is left as net profit.
  • What to watch: It earns only 1.1 CNY a year on every 100 CNY of invested capital.

Financial health

Can it carry its debt?

  • What speaks for it: It holds more cash than debt: ¥557.9M against ¥71.1M.

Capital and dividends

What does the company do with the money it earns?

  • What to watch: It pays out more in dividends than it earns: 432% of profit.

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage.

Privacy policy